Lexeo Therapeutics, Inc. LXEO
- LX2006 — Friedreich Ataxia Cardiomyopathy Phase 1
- LX3070 — Friedreich Ataxia Preclinical
FXN (4 companies · 5 programs)
Companies with an active program directed at FXN.
Larimar Therapeutics, Inc. LRMR
- nomlabofusp — Friedreich's Ataxia NDA Submitted
Solid Biosciences Inc. SLDB
- SGT-212 — Friedreich's Ataxia Phase 1
Voyager Therapeutics, Inc. VYGR
- frataxin gene therapy — Friedreich's Ataxia Preclinical